AURX · Nuo Therapeutics, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“We believe based on the operating cash requirements and capital expenditures expected for the next twelve months that our current resources and projected revenue from sales of Aurix products and the Private Label product to Smith+Nephew are insufficient to support our operations for the next 12 months from the date these financial statements are issued. As such, we believe that substantial doubt about our ability to continue as a going concern exists.”View the 10-Q filed Aug 14, 2026
Every disclosed holder of AURX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns AURX
13F quarter Jun 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 4,700 | 0.01% |
| Insiders (Forms 3, 4, 5) | 20,099,466 | 41.50% |
| 13D/G-only blocks | 4,209,824 | 8.69% |
| Remaining | 24,119,787 | 49.80% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 48,433,777, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of AURX
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
11,574,198 | ||
| 2 |
|
5,400,396 | ||
| 2.1 |
|
5,627,500 | ||
| 3 |
|
3,183,500 | ||
| 4 |
|
2,070,000 | ||
| 5 |
Deerfield Management Company, L.P.
13G
CIK 1352546 · Unknown · Sep 30, 2024
Rule 13d-1(c), passive investor
|
1,026,324 | ||
| 6 |
|
773,528 | ||
| 7 |
|
173,050 | ||
| 8 |
|
108,294 | ||
| 9 |
Ancora Advisors LLC
13F
CIK 1446114 · Registered investment adviser · Jun 30, 2026
|
4,700 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.